• Screening Immunocompromised Women for HPV-Related Lower Genital Tract Disease (OnDemand)

    Guidelines for cervical cancer screening have continued to evolve and integrate the latest evidence to support new technologies and algorithms. Most studies reported in the literature have included low-risk populations, leaving clinicians caring for medically complex and immunocompromised women uncertain of recommended screening strategies. During the webinar, Dr. Huchko will discuss patient populations who may require intensified screening, the state of the evidence for screening in immunocompromised women and current expert opinion about recommended screening strategies.



    Megan Huchko, MD, MPH

    Megan Huchko, MD, MPH is an Associate Professor at Duke University, with dual appointments in the Department of Obstetrics & Gynecology and the Duke Global Health Institute. Megan completed her residency training at Columbia Presbyterian in New York City, and a joint fellowship in Reproductive Infectious Disease and AIDS Prevention Studies at the University of California, San Francisco. At Duke, she is the Associate Chief and Director of Research for the Division of Women’s Community and Population Health and runs the Center for Global Reproductive Health. She practices as an ob/gyn generalist and specializes in cervical cancer prevention through her clinical work and global women’s health research and has published many peer reviewed articles about cervical cancer screening in different populations, including HIV-infected women.


    Registration Cost

    ASCCP Members: FREE Non-Member: $35.00


    Target Audience

    This activity is intended for physicians, physician assistants, midwives, nurse practitioners, nurses working in obstetrics and gynecology, gynecology oncology, oncology, internal medicine, family medicine and general practice.

    Educational Objectives

    • Describe the importance of cervical cancer screening
    • Describe the evolution of cervical cancer screening
    • Evaluate the strengths and shortcoming of methods of cervical cancer screening
    • Detail the recommendations for HPV screening as a method for cervical cancer screening

    Disclosure Information

    As an accredited provider of CME credit, ASCCP has implemented a process to ensure that anyone who is in a position to affect the content of an educational activity has disclosed all relevant financial relationships with any commercial interest. Any conflicts of interest have been resolved by ASCCP prior to the activity.

    The following person(s) disclosed no relevant financial relationships:

    • Megan Huchko, MD, MPH – Faculty
    • Elizabeth A. Kostas-Polston, PhD, APRN, WHNP – Content Reviewer
    • Peter F. Schnatz, DO – Content Reviewer
    • Kerry Curtis - Staff
    • Cate Langley - Staff
    • Cari Price - Staff
    • Alisha Yocum - Staff

    Continuing Medical Education (CME)

    ACCME Accreditation

    ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA PRA Category 1 Credit(s)TM

    ASCCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Purchase Access to the On-Demand Webinar

    Click here to watch the webinar and claim CME

Privacy Policy:


By using this site, you agree to the Privacy Policy and acknowledge the use of cookies to store information, which may be essential to making our site work properly or enhancing user experience.